EFFICACY OF NEW ORAL ANTICOAGULANTS IN THE TREATMENT OF SUPERFICIAL THROMBOPHLEBITIS COMPLICATED BY THROMBOSIS OF PERFORATING VEINS

Timerbulatov Mahmud Vilevich, Murasov Timur Mansafovich

In this work, a retrospective evaluation of the outcome of treatment of patients receiving new oral anticoagulants (rivaroxaban, dabigatran, apixaban) for thrombophlebitis of the superficial veins of the lower extremities, burdened with thrombosis of the perforant veins of the lower extremities, was performed. The medical history cards of 86 patients who used new oral anticoagulant drugs were analyzed. All patients were divided into 3 groups. In the first group, patients received rivaroxaban, in the second dabigastran etexilate, in the third apixaban. In the dabigatran etexilate group, a course of parenteral anticoagulants was previously performed for 5 days. At the control examinations, the quality of life of patients was assessed using a visual analog scale (VAS), and ultrasound duplex scanning was performed. The results of the analysis showed the effectiveness of new oral anticoagulants in the treatment of subcutaneous vein thrombophlebitis complicated by thrombosis of the perforated veins of the lower extremities.

Keywords:new oral anticoagulants, subcutaneous vein thrombophlebitis, perforant vein thrombosis, deep vein thrombosis, thrombophilia, crossectomy